Obesity Trial, Recruiting NCT07501377 Sponsor: Max Planck Institute for Human Cognitive and Brain Sciences Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07501377
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are in a specific stage of the transition toward menopause, known as the late reproductive or early menopausal transition stage (confirm with trial site for exact staging)
  • People with a body mass index (a measure of body weight relative to height) above 25, or a waist-to-hip ratio of 0.85 or higher, indicating higher weight or fat distribution around the abdomen
  • People with a blood test result showing a marker of inflammation in the body (called hsCRP) above 1 mg/l
  • People who have no reason they cannot undergo an MRI scan (for example, no metal implants or devices that are unsafe in MRI machines)
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • People who have experienced a significant mental health condition in the past 12 months, such as depression, substance misuse, an eating disorder, or schizophrenia
  • People who have type 1 diabetes
  • People who have previously had weight-loss surgery or stomach surgery
  • People who are currently pregnant or breastfeeding
  • People who have a severe untreated illness, have undergone cancer treatment in the last 12 months, or have any ongoing digestive condition (such as irritable bowel syndrome, Crohn's disease, or Helicobacter pylori infection) or any other ongoing inflammatory condition
  • People who have polycystic ovary syndrome, or who have had both ovaries surgically removed
  • People who have taken antibiotics in the past 3 months, or who have been taking high-dose inulin (more than 5g per day) or polyphenol supplements (more than 50mg per day) in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Registry
ClinicalTrials.gov
Start date
19 March 2026
Est. completion
30 June 2029

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Free water fraction averaged across the white matter skeleton

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov